BIO says that proposed changes to pharma patents would harm innovation
The Biotechnology Innovation Organization (BIO) recently told the U.S. Patent and Trademark Office (USPTO) that proposed changes to the pharmaceutical patent process are flawed—and would …
BIO says that proposed changes to pharma patents would harm innovation Read More »